Clinical trials
Terminated Observational Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ariad Pharmaceuticals | 1 |
| Asan Medical Center | 1 |
| Case Comprehensive Cancer Center | 1 |
| Columbia University | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| Kerman University of Medical Sciences | 1 |
| National Cancer Institute (NCI) | 1 |
| Stanford University | 1 |
| University of California, San Francisco | 1 |
| University of Michigan Rogel Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 10 |
| Leukemia | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma | 3 |
| Multiple Myeloma | 3 |
| Blast Crisis | 2 |
| Hematologic Neoplasms | 2 |
| Hodgkin Disease | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.